Jennifer Tousignant
General Counsel at VIRIDIAN THERAPEUTICS, INC.
Profile
Jennifer Tousignant is currently the Chief Legal Officer at Viridian Therapeutics, Inc. She previously worked as the Senior Vice President-Legal at Sana Biotechnology, Inc. and as a Member-Global Launch Teams at Genzyme Corp.
In addition, she served as the Head-Legal at Xilio Therapeutics, Inc. in 2020 and as the Chief Intellectual Property Counsel at Tesaro, Inc. from 2016 to 2019.
Ms. Tousignant completed her undergraduate studies at the University of Virginia and obtained a graduate degree from Suffolk University Law School.
Jennifer Tousignant active positions
| Companies | Position | Start |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | General Counsel | 2024-02-14 |
Former positions of Jennifer Tousignant
| Companies | Position | End |
|---|---|---|
| XILIO THERAPEUTICS, INC. | General Counsel | 2020-10-31 |
| TESARO INC | General Counsel | 2019-09-30 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| SANA BIOTECHNOLOGY, INC. | General Counsel | - |
Training of Jennifer Tousignant
| Suffolk University Law School | Graduate Degree |
| University of Virginia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Tousignant
